Research map: Association of ACE I/D polymorphism with blood pressure response to valsartan-hydrochlorothiazide combination therapy in hypertensive patients from Khyber Pakhtunkhwa, Pakistan

Back to the article

Papers in this map

  1. 2020 International Society of Hypertension Global Hypertension Practice Guidelines · Thomas Unger · 2020 · 4247 citations · Cited by this paper
  2. How to implement pre-emptive pharmacogenetic testing in the acute hospital setting · 2025 · Related
  3. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 · Simon I Hay · 2025 · 777 citations · Cited by this paper
  4. Opportunities and challenges for the implementation of pharmacogenomics in supportive care for gastrointestinal cancer patients in Zimbabwe · 2025 · Related
  5. Risk Factors for Nonadherence to Antihypertensive Treatment · Pankaj Gupta · 2017 · 257 citations · Cited by this paper
  6. ADIPOQ genotypes and haplotypes, circulating adiponectin levels and responsiveness to antihypertensive therapy in preeclampsia · 2025 · Related
  7. Genomics of hypertension: the road to precision medicine · Sandosh Padmanabhan · 2020 · 222 citations · Cited by this paper
  8. UGT1A6 variants and deferiprone-induced ADRs: a complication-specific analysis in Iranian thalassemia patients · 2025 · Related
  9. Management of Hypertension in CKD: Beyond the Guidelines · Eric K. Judd · 2015 · 163 citations · Cited by this paper
  10. Pharmacogenomic testing for Prader-Willi syndrome: a mixed methods analysis of caregiver experiences and utilization · 2025 · Related
  11. ACE and α-Adducin Polymorphism as Markers of Individual Response to Diuretic Therapy · Maria Teresa Sciarrone Alibrandi · 2003 · 158 citations · Cited by this paper
  12. Pharmacogenomics of anthracycline-cyclophosphamide-taxane chemotherapy: an influence of CYP polymorphisms and BMI on breast cancer treatment outcomes · 2025 · Related
  13. Non-communicable diseases and injuries in Pakistan: strategic priorities · Tazeen H. Jafar · 2013 · 140 citations · Cited by this paper
  14. Whole exome sequencing identifies rare variants involved in PPIX-metabolizing pathway in anti-TB drug-induced hepatitis · 2025 · Related
  15. Pharmacogenetics to guide cardiovascular drug therapy · Julio D. Duarte · 2021 · 138 citations · Cited by this paper
  16. Antiplatelet therapy in high-bleeding risk patients with acute coronary syndrome: pharmacogenomics in the era of precision medicine · 2026 · Related
  17. Does the Angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism modify the response to ACE inhibitor therapy? – A systematic review · Madlaina Scharplatz · 2005 · 42 citations · Cited by this paper
  18. Pharmacogenomics for stratified antidepressant treatment in major depressive disorder: evidence, limits and a roadmap for clinical use · 2026 · Related
  19. Clinical Pharmacogenetics of Angiotensin II Receptor Blockers in Iraq · Hany Akeel Al-Hussaniy · 2023 · 29 citations · Cited by this paper
  20. The association of ACE gene polymorphism with diabetic kidney disease and renoprotective efficacy of valsartan · Yuying Wang · 2016 · 18 citations · Cited by this paper
  21. Genetic polymorphisms influencing antihypertensive drug responses · Jana El Cheikh · 2024 · 13 citations · Cited by this paper
  22. Gender-Specific Association Between ACE Gene I/D Polymorphism and Blood Pressure Response to Hydrochlorothiazide in Han Chinese Hypertensive Patients · Yun Li · 2011 · 11 citations · Cited by this paper
  23. Pharmacogenomics in cardiovascular precision medicine · Zhou Zhou · 2020 · 11 citations · Cited by this paper
  24. DisGeReExT: a knowledge discovery system for exploration of disease–gene associations through large-scale literature-wide analysis study · Balu Bhasuran · 2023 · 3 citations · Cited by this paper

Source: OpenAlex (CC0)